Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Am Geriatr Soc. 2011 Sep 21;59(10):1793–1801. doi: 10.1111/j.1532-5415.2011.03601.x

Table 1.

Baseline Participant Characteristics by 25-Hydroxyvitamin D (25[OH]D) Status: CHS All Stars*

Total sample 25(OH)D
<20 ng/mL 20–<30 ng/mL ≥30 ng/mL P-value
N (%) 988 304 (30.8) 355 (35.9) 329 (33.3)
Age (yrs), mean ± SD 85.2 ± 3.6 85.2 ± 3.7 85.3 ± 3.7 85.1 ± 3.4 0.68
Female gender, % 64.5 66.1 60.8 66.9 0.20
Black race, % 16.7 30.3 13.0 8.2 <0.001
Field center, %
 Forsyth Co., NC 20.8 19.7 20.8 21.9 0.65
 Sacramento Co., CA 35.3 33.6 36.1 36.2
 Washington Co., MD 16.8 15.5 17.5 17.3
 Pittsburgh, PA 27.0 31.2 25.6 24.6
Education, %
 < High school 18.3 27.6 15.8 12.5 <0.001
 High school-some college 55.0 52.0 54.6 58.0
 ≥ College degree 26.7 20.4 29.6 29.5
Season, %
 Sep–Nov 31.0 25.7 30.7 36.2 0.05
 Dec–Feb 29.0 35.2 27.0 25.5
 Mar–May 14.5 15.1 15.2 13.1
 Jun–Aug 25.5 24.0 27.0 25.2
Smoking, %
 Never smoker 50.8 46.0 52.4 53.5 0.39
 Former smoker 45.8 50.0 44.2 43.5
 Current smoker 3.4 4.0 3.4 3.0
Weekly alcohol intake, %
 None 50.1 59.2 48.4 43.5 0.001
 1–7/wk 40.7 35.2 40.8 45.6
 >7/wk 9.2 5.6 10.7 10.9
Walking for physical activity in previous 2 weeks, %
 None 49.8 54.6 51.6 43.5 0.05
 <5 times/week 29.4 26.3 27.3 34.4
 ≥5 times/week 20.8 19.1 21.1 22.2
BMI status, %
 Normal weight (<25.0 kg/m2) 37.8 29.3 37.5 45.9 <0.001
 Overweight (25.0–29.9 kg/m2) 40.5 43.1 38.0 33.5
 Obese (≥30 kg/m2) 21.8 27.6 24.5 20.5
Creatinine (mg/dL), mean ± SD 1.09 ± 0.53 1.12 ± 0.68 1.04 ± 0.41 1.11 ± 0.48 0.08
Depression (CES-D score), mean ± SD 6.1 ± 4.7 6.8 ± 5.0 6.0 ± 4.6 5.6 ± 4.4 0.003
Cognition (3MSE score), mean ± SD 88.6 ± 10.7 86.4 ± 10.8 89.3 ± 9.8 89.7 ± 11.4 <0.001
Prevalent disease, %
 Diabetes 14.5 21.0 13.2 9.7 <0.001
 Hypertension 64.0 66.1 61.7 64.4 0.49
 Osteoporosis 23.7 14.8 25.6 29.8 <0.001
 Knee arthritis 27.7 29.0 28.4 25.8 0.64
 CVD 22.9 26.0 23.9 18.8 0.08
*

Means ± SD or frequencies with chi-square or ANOVA to evaluate the distribution across categories of 25(OH)D.

CVD: myocardial infarction, congestive heart failure, and stroke.